Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RBM7 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → RBM7 |
| (<<) CTGF → RBM7 |
| (<<) DDX18 → RBM7 |
| (<<) ITGAV → RBM7 |
| (<<) NFAT5 → RBM7 |
| (<<) PGK1 → RBM7 |
| (<<) POLR1B → RBM7 |
| (<<) RNF111 → RBM7 |
| (<<) SMARCC2 → RBM7 |
| (<<) UBE2D2 → RBM7 |
| (<<) UBE2D3 → RBM7 |
| (<<) YWHAQ → RBM7 |
| Downstream (Children) |
|---|
| RBM7 → AKAP12 (>>) |
| RBM7 → ASB1 (>>) |
| RBM7 → ATP2A2 (>>) |
| RBM7 → BCL3 (>>) |
| RBM7 → CASP3 (>>) |
| RBM7 → CCND1 (>>) |
| RBM7 → CD3EAP (>>) |
| RBM7 → CEND1 (>>) |
| RBM7 → COIL (>>) |
| RBM7 → E2F6 (>>) |
| RBM7 → ELF1 (>>) |
| RBM7 → EMP1 (>>) |
| RBM7 → GDF15 (>>) |
| RBM7 → GNB2L1 (>>) |
| RBM7 → GNG12 (>>) |
| RBM7 → GYS1 (>>) |
| RBM7 → HGS (>>) |
| RBM7 → HLA-A (>>) |
| RBM7 → HLA-G (>>) |
| RBM7 → HRAS (>>) |
| RBM7 → ICAM1 (>>) |
| RBM7 → LIG1 (>>) |
| RBM7 → MAPK9 (>>) |
| RBM7 → NEDD4 (>>) |
| RBM7 → NFKB1 (>>) |
| RBM7 → NFKBIA (>>) |
| RBM7 → ODC1 (>>) |
| RBM7 → PRKAA1 (>>) |
| RBM7 → PRR5 (>>) |
| RBM7 → RAP1A (>>) |
| RBM7 → RASA1 (>>) |
| RBM7 → RHOA (>>) |
| RBM7 → RHOT2 (>>) |
| RBM7 → RNF11 (>>) |
| RBM7 → RNF138 (>>) |
| RBM7 → RPS12 (>>) |
| RBM7 → SCG5 (>>) |
| RBM7 → SERPINB1 (>>) |
| RBM7 → SPDEF (>>) |
| RBM7 → STEAP1 (>>) |
| RBM7 → SULT1A1 (>>) |
| RBM7 → TCOF1 (>>) |
| RBM7 → TRIB1 (>>) |
| RBM7 → WNT3 (>>) |
